$Cassava Sciences (SAVA.US)$ Report stock soared on Thursday...

$Cassava Sciences(SAVA.US)$ Report stock soared on Thursday after the biotech said it had been informed by the Journal of Neuroscience that there is no evidence of data manipulation in an article it published in describing a new approach to treating Alzheimer's disease.
Shares of the Austin company at last check were 36% higher at $77.15. They've traded on Thursday as high as $100, up 76%.